Moderna

"Whether it’s leading a team, managing complex security threats, or making critical decisions in high-stakes environments, the lessons I learned during my service have been invaluable. I am continually reminded that service doesn’t stop when you leave the military—it’s a lifelong commitment to making a difference wherever you are.” This #VeteransDay, Dean Geribo, our VP of Global Corporate Security and a United States Marine Corps veteran, leads us in honoring the courage, sacrifice, and commitment of those who have served our country. Read more from Dean who also serves as the Executive Sponsor of our Employee Resource Group, mVETS: https://lnkd.in/e6kFXdtE

For #WorldImmunizationDay, we’re reflecting on centuries of scientific innovations in #vaccines and looking ahead to an even brighter future fueled by innovative technologies that allow for greater speed and scale of development. 🌎 Join us in a look back at vaccines throughout history: https://lnkd.in/esRYhrBz

Whether it’s a phone notification, an old-fashioned paper planner, or something else, make sure you set a reminder to get your updated #COVID19 #vaccine. If you had COVID in August or earlier during the summer surge, you should get an updated vaccine this month! Protect yourself and your loved ones – find a vaccine near you: http://foryouandthem.com.

Our commitment to learning fuels our innovation every day. This mindset is especially important as we celebrate #NationalSTEMDay, which serves as a powerful reminder of the role education plays in shaping the future. From our mRNAs as Medicines course on Coursera to partnerships with organizations like Science Club for Girls, we hope to make #STEM education more accessible. 🔬🧪✨ Read more from our Chief Learning Officer, Molly Nagler: https://lnkd.in/eJXu8q-e

We announced today that Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for Adults Aged 60 Years and Older. Learn more: https://lnkd.in/evS35KzT

Earlier today, we reported financial results and provided business updates for the third quarter of 2024. For the latest episode of our #IRInsights series, members of our executive team sat down to provide more insight into our financial performance and upcoming late-stage pipeline milestones. Watch the full video here: https://lnkd.in/e5Dgp-nF

Today, we reported financial results and provided business updates for the third quarter of 2024. Read more: https://lnkd.in/edz_Bdsx

Join us at the Boston Globe Media’s first annual Future of Medicine event on Nov. 13 to hear from Kyle Holen, our Head of Development, Oncology and Therapeutics who will be joined by Patrick Ott of Dana-Farber Cancer Institute and Jacalyn Rosenblatt of Beth Israel Deaconess Medical Center to discuss precision approaches shaping the future of cancer care. Learn more: https://lnkd.in/e87Q3Ppx

We're implementing AI use cases across our entire value chain—from research to commercialization—to help advance the development of #mRNA medicines. Discover how we’re leveraging generative AI and large language models to empower our employees and unlock innovative treatments. Read more from Fortune: https://lnkd.in/eFJXgKAt

Over the summer, the U.S. experienced one of the biggest #COVID19 waves in the past two years. In its updated guidance, the CDC recommends that people who recently had a COVID-19 infection should consider waiting up to three months from your first symptoms or, if the infection was asymptomatic, a positive test, to get their updated COVID-19 vaccine. So if you had COVID in August or earlier, you should get an updated vaccine this month! Learn more: https://lnkd.in/eP76aMXD